Judy D. Olian

Director, United Therapeutics; Director, Ares Management

Bought, 12 months

$0.1M

Sold, 12 months

$0.4M

Companies

Latest trade

Mar 23, 2026

Companies

United TherapeuticsDirector −$0.4M Ares ManagementDirector +$0.1M

Trades

UTHR Sold 200 shares at $530.00 · planned $0.1M Mar 23

UTHR Sold 200 shares at $535.44 · planned $0.1M Mar 16

UTHR Sold 200 shares at $510.00 · planned $0.1M Mar 6

UTHR Sold 200 shares at $509.55 · planned $0.1M Feb 27

ARES Bought 480 shares at $124.43 $0.1M Feb 20

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.